RxDoctor Payments Data

Joseph Jowers, MD

Family Medicine · Cullman, ALNPI 1689641367

Payments from drug & device makers

$3,526in general payments, 2019–2025

Across 194 payments — averaging $18.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$466
  • AbbVie$430
  • GSK$255
  • Abbott$206
  • AstraZeneca$204
  • Axsome Therapeutics, Inc.$186
  • plus $2K from 32 others

What the payments were for

  • Food & beverage$3,526100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,526 in reported general payments places this provider in the 75th percentile of 1,680 family medicine providers in Alabama.

See all family medicine providers in Alabama

Medicare billing

Part B allowed, 2024
$86,143
Medicare patients
203
Services billed
1,617

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide86$100,411
EliquisApixaban64$59,244
MounjaroTirzepatide44$48,937
Trelegy ElliptaFluticasone/Umeclidin/Vilanter61$41,939
JanuviaSitagliptin Phosphate42$35,357
XareltoRivaroxaban26$29,817
JardianceEmpagliflozin34$28,580
TrulicityDulaglutide17$26,656
Tresiba Flextouch U-100Insulin Degludec36$16,814
Tresiba Flextouch U-200Insulin Degludec24$15,785
EntrestoSacubitril/Valsartan11$15,075
Breo ElliptaFluticasone/Vilanterol19$10,305
FarxigaDapagliflozin Propanediol15$9,720
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$9,604
Atrovent HfaIpratropium Bromide16$7,105

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$466$100,41186 claims
Lilly USA, LLCMounjaro, Trulicity$180$75,59361 claims
PfizerEliquis$151$59,24464 claims
GSKTrelegy Ellipta, Breo Ellipta$255$52,24480 claims
MerckJanuvia$134$35,35742 claims
Boehringer IngelheimJardiance$35$28,58034 claims
AstraZenecaFarxiga, Breztri Aerosphere$204$19,32430 claims
NovartisEntresto$68$15,07511 claims
AbbVieSynthroid$430$2,44926 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,680 family medicine providers in Alabama.

Other family medicine in Cullman

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →